The cell culture media market is on the cusp of remarkable growth, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 6.66% over the next decade. Valued at USD 3,513.8 million in 2024, the market is expected to soar to an impressive USD 6,699.93 million by 2034.
This dynamic expansion reflects the increasing reliance on cell culture media in a variety of biotechnological and pharmaceutical applications. As the demand for advanced research and development in cell biology, drug discovery, and regenerative medicine escalates, the cell culture media market is set to experience substantial growth.
Get your PDF Sample Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-14366
The desire for personalized medication and the rising demand for biopharmaceutical goods are the main factors driving the growth of the cell culture industry. Pharmaceutical companies are extensively investing in cell culture technology to create new medications and enhance existing ones, as the prevalence of chronic diseases rises. The need for sophisticated cell culture methods has also increased as a result of the growth of tissue engineering and regenerative medicine.
The market is also expanding because to creative solutions and technological breakthroughs. To better replicate in vivo settings, scientists are always creating better culture medium, bioreactors, and 3D cell culture systems. These developments enhance cell viability, productivity, and overall efficiency, meeting the growing requirements of the biotechnology and pharmaceutical sectors.
Competitive Landscape:
Important companies like Avantor, Inc., Thermo Fisher Scientific, Inc., Caisson Laboratories Inc., Becton Dickinson and Company, Lonza Group AG, Bio-Rad Laboratories, Inc., General Electric Company, etc. are present in the worldwide cell culture media market.
Many businesses are making significant investments in R&D to develop novel and specialized formulations of cell culture medium. The aforementioned tasks involve creating specified and serum-free media, refining current formulations, and integrating cutting-edge technology to fulfill the dynamic requirements of biopharmaceutical and life sciences research.
Recent Developments
- On July 12, 2023, Merck announced the expansion of its Lenexa, Kansas facility, making it the company’s largest dry powder cell culture media facility and Center of Excellence in North America.
- In October 2023, London-based startup Multus Biotechnology focused on cutting the cost of cell culture media for cultivated meat by leveraging AI to optimize formulation efficiency. The startup addresses challenges in ingredient quality, scalability, and bioprocess productivity, aiming to enhance the sustainability and cost-effectiveness of cell culture media.
- On July 27, 2023, MilliporeSigma invested $25 million to expand its cell culture media production facility in Lenexa, Kansas. The expansion included 98,000 ft2 of lab space, reinforcing the company’s commitment to meeting the increasing demand for cell culture media. Lenexa now serves as one of the three global centers of excellence for dry powder cell culture media manufacturing.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-14366
Key Companies in the Market:
- Avantor, Inc.
- Thermo Fisher Scientific, Inc.
- Caisson Laboratories Inc.
- Becton Dickinson and Company
- Lonza Group AG
- Bio-Rad Laboratories, Inc.
- General Electric Company
- Cell Culture Technologies LLC
- Corning Incorporated
- Fujifilm Holdings Corporation
- Hi Media Laboratories Pvt. Ltd.
- Merck & Co., Inc.
Market Segmentation:
By Type:
- Serum-free Media
- CHO Media
- HEK 293 Media
- BHK Media
- VERO Cell Media
- Insect Cell Media
- Serum-free Stem Cell Media
- CAR T-cell Media
- Other Serum-free Media
- Classical Media & Salts
- Stem Cell Culture Media
- Specialty Media
- Chemically defined Media
- Other Cell Culture Media
By Application:
- Biopharmaceutical Production
- Monoclonal antibodies
- Cancer Research
- Vaccines production
- Other therapeutic proteins
- Diagnostics
- Drug Screening & Development
- Tissue Engineering & Regenerative Medicine
- Cell and gene therapy
- Other tissue engineering & regenerative medicine applications
- Other Application
By End User:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Explore Comprehensive Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14366
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
